Trends in inflammatory bowel disease and pancreatic cancer: an analysis of the National Inpatient Sample database.

Autor: Kimchy AV; Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC (Alexandra V. Kimchy)., Ahmad AI; Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC (Akram I. Ahmad, Shiva Vangimalla)., Wikholm C; Georgetown University School of Medicine, Washington, DC (Colin Wikholm, Won K. Cho)., Vangimalla S; Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC (Akram I. Ahmad, Shiva Vangimalla)., Cho WK; Georgetown University School of Medicine, Washington, DC (Colin Wikholm, Won K. Cho).; Division of Gastroenterology and Hepatology, INOVA Medical System, Leesburg, VA (Won K. Cho), USA.
Jazyk: angličtina
Zdroj: Annals of gastroenterology [Ann Gastroenterol] 2023 May-Jun; Vol. 36 (3), pp. 307-313. Date of Electronic Publication: 2023 Apr 06.
DOI: 10.20524/aog.2023.0791
Abstrakt: Background: An association between inflammatory bowel disease (IBD) and pancreatic cancer has been suggested in the literature. We aimed to determine the trend in prevalence of pancreatic cancer amongst patients hospitalized for Crohn's disease (CD) or ulcerative colitis (UC) in the United States.
Methods: An analysis of the National Inpatient Sample database was performed to identify adults diagnosed with pancreatic cancer and CD or UC, using validated ICD-9 and ICD-10 codes, from 2003-2017. Age, sex, and racial demographics were also collected. Surveillance, Epidemiology and End Results registry (SEER) data were analyzed for trends in the incidence and mortality of pancreatic cancer amongst the general population in the United States.
Results: From 2003-2017, there was a significant increase in the hospitalizations related to pancreatic cancer, from 0.11% to 0.19% (P Trend <0.001), representing a 72.73% increase, in CD patients, and from 0.08% to 0.38% (P Trend <0.001), representing a 375.00% increase, in UC patients. According to the SEER 13 data on pancreatic cancer in the general population, the incidence of pancreatic cancer increased from 11.34 per 100,000 cases in 2003 to 12.74 per 100,000 cases in 2017, thus representing only a 12.35% increase over the study period.
Conclusions: Our study indicates a trend for increasing prevalence of pancreatic cancer in patients hospitalized with CD and UC from 2003-2017 in the United States. This increasing trend observed in the IBD population parallels the increase in the incidence of pancreatic cancer reported among the general population, but at a much greater rate.
Competing Interests: Conflict of Interest: None
(Copyright: © Hellenic Society of Gastroenterology.)
Databáze: MEDLINE
Externí odkaz: